The Tri-Institutional MD-PhD Program (Tri-I) is a joint undertaking between Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center. Trainees complete their MD degree at Weill Cornell Medical College, and PhD training at one of the three participating graduate schools: Weill Cornell Graduate School of Medical Sciences; the David Rockefeller Graduate Program in Bioscience; or the Louis V. Gerstner Jr. Graduate School of Biomedical Sciences. Tri-I guides students through a rigorous course of study that offers flexibility and unfettered access to experienced mentors in leading laboratories. An integrated curriculum reinforces the students’ identities as clinician-scientists; equally well-prepared to work in the laboratory and at the bedside, Tri-I graduates bridge the gap between clinical medicine and laboratory research. 

Learn more about the Tri-Institutional MD-PhD Program by watching the short video below.

Aleksandr Talishinsky, PhD, received an NIH F30 research grant to support his work in the Liston Lab at Weill Cornell Graduate School. Dr. Talishinsky, who defended his thesis in October of 2021, described his research below:
In keeping with the spirit of the season, it is with gratitude that I write my first newsletter as the Director of the Tri-Institutional MD-PhD Program. These first few months of my Directorship have truly been a whirlwind, as I have navigated meeting our students in COVID-safe settings, participated in my first white coat ceremony, sampled the delicious (and potent) House libations, and interviewed all of the incredible applicants hoping to join the Tri-I in 2022.